• Temafloxacin (SKU BA1108): Reliable Solutions for Infection

  2026-06-03

  This article provides scenario-driven guidance for researchers working with cell viability, proliferation, and cytotoxicity assays, demonstrating how Temafloxacin (SKU BA1108) from APExBIO delivers reproducible, evidence-based results in antibacterial research. Integrating quantitative data and best practices, it offers practical answers to common laboratory challenges in Gram-positive and Gram-negative infection models.

• Vancomycin: Glycopeptide Antibiotic for MRSA & C. difficile

  2026-06-02

  Vancomycin is a glycopeptide antibiotic that inhibits bacterial cell wall synthesis, making it indispensable for research on MRSA and Clostridium difficile. Its efficacy, purity, and mechanistic specificity establish it as a benchmark antibacterial agent in resistance studies.

• Hoechst 33342 Nuclear Stain: Precision in Live Cell Assays

  2026-06-02

  Hoechst 33342 Solution (1 mg/mL) offers exceptional nuclear staining fidelity for both live and fixed cell workflows, enabling robust senescence and mitochondrial quality analysis. Its high cell permeability and low cytotoxicity are game-changers for advanced fluorescence microscopy and flow cytometry applications. Discover protocol enhancements and troubleshooting strategies for reproducible, high-contrast nuclear labeling.

• Ceftolozane Sulfate: Applied Workflows in Antibacterial Rese

  2026-06-01

  Ceftolozane sulfate offers robust, resistance-aware protocols for dissecting Pseudomonas aeruginosa responses and PK/PD dynamics. This article delivers step-by-step workflow enhancements, advanced troubleshooting, and key innovations from recent resistance modeling studies—empowering translational researchers to optimize every phase of their antibacterial assay.

• Disulfiram: Dopamine β-Hydroxylase Inhibitor for Cancer Rese

  2026-06-01

  Disulfiram, a clinically established dopamine β-hydroxylase inhibitor, is now recognized for its potent inhibition of proteasomal chymotrypsin-like activity and induction of apoptotic cancer cell death. Robust evidence shows Disulfiram’s copper-dependent action in breast cancer MDA-MB-231 models, with clear in vitro and in vivo protocols established. This article provides a benchmarked, machine-readable guide for researchers leveraging Disulfiram in advanced cancer and cell death studies.

• Sodium dicloxacillin monohydrate: Optimizing MSSA Research W

  2026-05-31

  Sodium dicloxacillin monohydrate offers precision control in Gram-positive bacterial infection research, enabling robust study of methicillin-sensitive Staphylococcus aureus (MSSA) through well-validated, reproducible workflows. Discover advanced protocol optimization strategies, troubleshooting insights, and the latest data-driven approaches to maximize the reliability and translational value of your infection models.

• Aztreonam: Applied Research on Monocyclic β-Lactam Antibioti

  2026-05-30

  Aztreonam, a synthetic monocyclic β-lactam antibiotic, offers unique capabilities for dissecting Gram-negative resistance, bone marrow toxicity, and hepatic metabolism in translational research. This article delivers detailed workflows, troubleshooting strategies, and key insights from recent epidemiological studies—empowering researchers to optimize Aztreonam-based experiments in antimicrobial and pharmacological contexts.

• Defining Proteoform-Specific Drug Interactions in Native Sig

  2026-05-29

  This study pioneers the direct analysis of proteoform-specific interactions between membrane proteins and small molecules within native lipid environments using advanced mass spectrometry. The findings reveal how post-translational modifications and alternative splicing shape drug binding, offering new avenues for precision pharmacology and therapeutic development.

• In Vitro Susceptibility of Staphylococci to Mupirocin and No

  2026-05-29

  This study by Fulham et al. systematically assessed the in vitro susceptibility of meticillin-resistant and meticillin-susceptible staphylococci from dogs to mupirocin and novobiocin, using rigorous microbiological techniques. The findings highlight the continued efficacy of mupirocin against both MSS and MRS isolates, while revealing reduced susceptibility of MRS to novobiocin, underscoring the need for informed antimicrobial selection in veterinary dermatology.

• Z-VAD-FMK in Apoptosis Research: Protocols and Innovations

  2026-05-28

  Unlock the full potential of Z-VAD-FMK in dissecting caspase-dependent cell death, with advanced workflow insights and troubleshooting strategies. This guide bridges recent mechanistic breakthroughs with hands-on laboratory protocols for reproducible, high-impact apoptosis inhibition studies.

• Ciprofloxacin Hydrochloride: Next-Gen Insights for Translati

  2026-05-28

  This thought-leadership article, authored by APExBIO's Head of Scientific Marketing, delivers a nuanced exploration of ciprofloxacin hydrochloride as both a fluoroquinolone antibiotic and a translational tool. We synthesize mechanistic discoveries, single-cell antibiotic antagonism findings, and practical guidance for researchers seeking to optimize antibacterial, immunomodulatory, and stress-response models. Enhanced by scenario-driven best practices and cross-linked to leading protocols, this article stakes new ground beyond conventional product pages—equipping investigators to maximize the impact and reproducibility of their antimicrobial experiments.

• Benzyl Quinolone Carboxylic Acid in M1 Receptor Assay Workfl

  2026-05-27

  Benzyl Quinolone Carboxylic Acid (BQCA) enables precise, reproducible potentiation of M1 muscarinic acetylcholine receptor signaling, accelerating research in cognitive enhancement and Alzheimer's disease. This guide translates reference-driven insights and real-world protocols into actionable experimental strategies, troubleshooting, and advanced applications for neuroscience labs.

• Applied Workflows and Innovation with Cefazedone (Refosporen

  2026-05-27

  Cefazedone (Refosporen), available from APExBIO, empowers researchers with robust, β-lactamase-resistant activity for both in vitro and in vivo models of Gram-positive and Gram-negative infections. This article translates recent workflow enhancements, pharmacokinetic breakthroughs, and troubleshooting strategies into actionable protocols for antibacterial research and clinical translation.

• Tyrothricin Peptide Antibiotic Mixture: Protocols & Troubles

  2026-05-26

  Tyrothricin, a robust peptide antibiotic mixture from APExBIO, delivers reproducible, broad-spectrum antimicrobial activity for advanced infection control assays. This guide covers optimized workflows, protocol refinements, and troubleshooting strategies, with direct translation of recent mechanistic findings and workflow insights.

• Exome Sequencing Reveals UV and TSA Mutation Signatures in K

  2026-05-26

  This study leverages exome sequencing to comprehensively profile mutation signatures induced by UVB radiation and trichostatin A (TSA) in primary human keratinocytes. Key findings include the identification of novel UV-induced mutation motifs and the dual role of TSA as both a chromatin-modifying protector and a mutagen, offering new insights into mutagenesis and skin cancer risk.

452 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page